Outcome study following reimbursement changes in the use of fixed combination inhalers in patients with asthma or Chronic Obstructive Pulmonary Disease

Study identifier:NIS-RSE-DUM-2010/2

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Outcome study following reimbursement changes in the use of fixed combination inhalers in patients with asthma or COPD in Iceland

Medical condition

asthma

Phase

Healthy volunteers

Study drug

Sex

All

Actual Enrollment

20000

Study type

Observational

Age

N/A

Date

Study Start Date: 01 Jul 2011

Primary Completion Date: 01 Sept 2013

Study Completion Date: 01 Sept 2013

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Sept 2014 by AstraZeneca Pharmaceuticals

Collaborators

Inclusion and exclusion criteria

Location

Research Site

Uppsala, Sweden

Arms	Assigned Interventions
1 All patients who was on treatment with fixed combination asthma or COPD therapy by January 1 2010	-

"There is no result for the study"

Documents available

NIS-RSE-DUM-2010/2 Revised Protocol 2.0 Redacted
Download
CSR Synopsis
Download
Trial Results Summaries
Available here

Contacts

Contact

AstraZeneca Nordic Clinical Study Information

+46 (0)8 553 26 000

Investigators

Principal Investigator

Unnur Steina Björnsdottir

University of Iceland